Kantum Bio's Debt Round

Kantum Bio raised a round of funding on April 30, 2018.

Kantum Diagnostics, dba Kantum Bio, is developing two programs in parallel: (1) Selective receptor antagonist-based therapeutics for AKI and (2) a UDP-G diagnostic test. Kantum's lead therapeutic deve…

Articles about Kantum Bio's Debt Round: